AnalystsAmi FadiaAmi Fadia's Stock Forecasts
AnalystsAmi Fadia
Analyst Ranking
Top 7%
#306 out of 4565 analysts
Average Return
+7.46%
Win Rate
46%97 out of 209
Risk vs Reward
Poor
Good
Ami Fadia's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +149.13% | $19.46 | $48.48 | 2023-03-01 - 2024-02-29 | Buy |
Merus NvMRUS | +143.86% | $18.33 | $44.70 | 2023-04-06 - 2024-04-05 | Buy |
Blueprint Medicines CorpBPMC | +134.58% | $40.52 | $95.05 | 2023-02-27 - 2024-02-26 | Buy |
Blueprint Medicines CorpBPMC | +125.28% | $42.37 | $95.45 | 2023-02-28 - 2024-02-28 | Buy |
Pacira Biosciences IncPCRX | +121.29% | $31.43 | $69.55 | 2020-03-20 - 2021-01-21 | Buy |
Ami Fadia Analyst Color
Get additional color on Ami Fadia's coverage of popular stocks
Ami Fadia's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 25 | Buy | $294.00 | +45.21% | Reiterates | 2 days ago |
Day One Biopharmaceuticals IncDAWN | 11 | Buy | $33.00 | +149.81% | Reiterates | 2 days ago |
Intra Cellular Therapies IncITCI | 17 | Buy | $90.00 | +24.77% | Maintains | 4 days ago |
Immuneering CorpIMRX | 6 | Buy | $15.00 | +948.95% | Reiterates | 15 days ago |
Revolution Medicines IncRVMD | 10 | Buy | $46.00 | +30.20% | Maintains | 15 days ago |
Harmony Biosciences Holdings IncHRMY | 18 | Buy | $50.00 | +72.83% | Reiterates | 15 days ago |
Merus NvMRUS | 15 | Buy | $66.00 | +46.90% | Reiterates | 16 days ago |
Bicycle Therapeutics PLCBCYC | 10 | Buy | $43.00 | +90.94% | Reiterates | 17 days ago |
Avadel Pharmaceuticals PLCAVDL | 21 | Buy | $22.00 | +23.46% | Reiterates | 18 days ago |
Acadia Pharmaceuticals IncACAD | 3 | Buy | $32.00 | +96.20% | Reiterates | 18 days ago |
Jazz Pharmaceuticals PLCJAZZ | 16 | Buy | $220.00 | +104.78% | Reiterates | a month ago |
Blueprint Medicines CorpBPMC | 15 | Buy | $97.00 | +6.91% | Reiterates | 2 months ago |
Cogent Biosciences IncCOGT | 12 | Buy | $18.00 | +199.50% | Reiterates | 2 months ago |
Sage Therapeutics IncSAGE | 6 | Buy | $70.00 | +415.46% | Reiterates | 9 months ago |
Theseus Pharmaceuticals IncTHRX | 5 | Buy | $23.00 | +466.50% | Reiterates | a year ago |
Seagen IncSGEN | 6 | Buy | $185.00 | N/A | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Amryt Pharma PLCAMYT | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $26.00 | N/A | Maintains | 3 years ago |
Amarin Corp PLCAMRN | 1 | Buy | $16.00 | N/A | Maintains | 3 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $75.00 | N/A | Downgrades | 3 years ago |
Obseva SaOBSVF | 1 | Buy | $5.00 | N/A | Maintains | 3 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Hold | $13.65 | N/A | Maintains | 4 years ago |
Iterum Therapeutics PLCITRM | 4 | Hold | $22.50 | N/A | Maintains | 4 years ago |
Perrigo Co PLCPRGO | 3 | Buy | $63.00 | N/A | Maintains | 4 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Upgrades | 6 years ago |
Endo International PLCENDPQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 6 years ago |
Heron Therapeutics IncHRTX | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 6 years ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Strong Sell | $13.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.